Over the past few years, innovative technologies have emerged to achieve the excellent wound closure outcomes. Appropriate wound care can facilitate healing, decrease pain and improve the overall quality of life. Knotless tissue control devices provides a new tool for soft tissue fixation. Knotless tissue control devices eliminate the need to tie surgical knots and reduces the operating room time and complications related to potential knots. Knotless tissue control devices reduces the difficulty in suturing especially in minimally invasive gynecological procedures by eliminating the knots. The device has a barb design to aid high strength soft tissue approximation along with the absorption and performance characteristics. The benefits and features of the barb design (anchors) may increase the efficiency of tissue approximation while ensuring the appropriate wound support during healing. Knotless tissue control device is an antibacterial monofilament and a synthetic absorbable device prepared from a copolymer of ε-caprolactone and glycolide. Knotless tissue control device consists of barbed suture material, armed with a fixation loop on one end and a surgical needle at the opposite end. Knotless tissue control devices also offer the additional benefit of addressing some of the risk factors associated with the surgical site infections.
According to the new WHO Guidelines, “the panel suggests the use of triclosan-coated sutures for the purpose of reducing the risk of surgical site infection (SSI), independent of the type of surgery.”
Knotless Tissue Control Devices Market: Drivers and Restraints, Overview, Regional Overview, Key Players
Over time, the demand for medical devices has increased significantly. Furthermore, technological advancement, rise in demand for minimal invasive procedures and increasing surgical processes are the key factors responsible for the growth of global knotless tissue control devices. In addition, the development of cost effective products will further contribute the market growth. However, the high products cost of wound closure, lack of proper reimbursement policies and technical assistance for using wound closure products will inhibit the market growth of the global knotless tissue control devices.
Knotless tissue control devices reduces the need for other products and endoscopic suturing devices. These devices close dermal wounds up to 50% faster when compared to traditional devices. Knotless tissue control devices eliminates the need for knots which are the weakest point of the suture closure. The knotless tissue control devices has some advantages like they provide distribution of tension along the wound, eliminates time consuming and tedious knot tying and potential to reduce knot related complications.
Based on end user, the global knotless tissue control devices market is segmented into hospitals, ambulatory surgical centers, trauma centers, medical device manufacturers, pharmaceutical companies and research centers & laboratory.
Region wise, the global knotless tissue control devices market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America expected to dominate the global knotless tissue control devices market with high adoption of medical device services, wide availability of medical devices manufacturers and biotechnology companies. Similarly, large patient pool in the Asia –Pacific excluding Japan market are expected to boost the growth of the knotless tissue control devices market.
The key players in the global knotless tissue control devices market are Medtronic, Johnson & Johnson Services, Inc., Ethicon US, LLC. (Subsidiary of Johnson & Johnson), and Medline Industries, Inc.
Request to Sample Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-5530